Status:
RECRUITING
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
Lead Sponsor:
Uppsala University
Conditions:
Dupuytren Contracture
Dupuytren's Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dupuytren's contracture (DC) is associated with progressive finger flexion and extension deficit caused by fibrosis in the palm and digits. Treatment options include minimally invasive procedures such...
Eligibility Criteria
Inclusion
- 18 years of age and older,
- Palpable Dupuytren strand with passive extension deficit according to stadium 1 and 2 of the classification of Tubiana in one or two fingers excluding the thumb, defined as at least 30 degrees in the MCP joint and/or at least 20 degrees in the PIP joint and a maximum of 75 degrees in the MCP or PIP joint
Exclusion
- Multiple, invasive or wide strands in the palm,
- Skin irritation,
- Strand localization in the digit only,
- Digital nerve injury,
- Any former treatment for Dupuytren's contracture in the same digit,
- Thumb contracture,
- Stadium 3 and 4 according to the classification of Tubiana
Key Trial Info
Start Date :
September 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT05300893
Start Date
September 14 2022
End Date
January 1 2027
Last Update
May 31 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Falu Lasarett
Falun, Dalarna County, Sweden, 79182
2
Akademiska Sjukhuset
Uppsala, Uppsala County, Sweden, 75185
3
Universitetssjukhuset Örebro
Örebro, Örebro County, Sweden, 70185